Biocon (NSE:BIOCON) Short Interest


NSE:BIOCON Biocon Ltd NSE:BIOCON
85 GF Score
Price ₹418.60
GF Value ₹339.27
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Biocon Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:BIOCON vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Biocon's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biocon Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biocon's Short Interest distribution charts can be found below:

* The bar in red indicates where Biocon's Short Interest falls into.


NSE:BIOCON
85GF Score
Biocon Ltd NSE:BIOCON
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biocon (NSE:BIOCON) Overvalued in 2026?

Based on GuruFocus' analysis, Biocon stock appears to be overvalued. The current stock price of ₹418.60 is trading 23.4% above its estimated GF Value™ of ₹339.27. GuruFocus considers Biocon to be Modestly Overvalued.

Key valuation signals for NSE:BIOCON:

  • Short Interest:
  • GF Value™: ₹339.27 vs. price of ₹418.60 (23.4% above fair value)
  • GF Score™: 85/100 with 10 warning signs

No single metric tells the full story. See the NSE:BIOCON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biocon Business Description

Other Exchanges 532523:India
Address 20th KM, Hosur Road, Electronics City, Bengaluru, KA, IND, 560100
Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Biosimilars which derives maximum revenue, Generics, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene. Geographically, the company generates a majority of its revenue from its customers located in India and the rest from Brazil, Singapore, and the rest of the world.
85GF Score

Get the complete analysis for NSE:BIOCON

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹418.60
Price
₹339.27
GF Value